CLINICAL TRIALS PROFILE FOR GADOFOSVESET TRISODIUM
✉ Email this page to a colleague
All Clinical Trials for GADOFOSVESET TRISODIUM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01135316 ↗ | Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR | Completed | Lantheus Medical Imaging | 2009-10-01 | Phase 4, open-label, two-year, prospective, multi-center, follow-up study conducted at up 15 sites in USA. Approximately 1,000 patients with moderate-to-severe CKD will be enrolled and followed for up to 24 months. | |
NCT01165892 ↗ | Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) | Completed | Lantheus Medical Imaging | 2011-07-01 | The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI). | |
NCT01165892 ↗ | Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) | Completed | Washington University School of Medicine | 2011-07-01 | The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI). | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GADOFOSVESET TRISODIUM
Condition Name
Clinical Trial Locations for GADOFOSVESET TRISODIUM
Trials by Country
Clinical Trial Progress for GADOFOSVESET TRISODIUM
Clinical Trial Phase
Clinical Trial Sponsors for GADOFOSVESET TRISODIUM
Sponsor Name